BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11859423)

  • 1. Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease.
    Maury S; Litvinova E; Boyer O; Benard L; Bruel S; Klatzmann D; Cohen JL
    Gene Ther; 2002 Feb; 9(3):201-7. PubMed ID: 11859423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered T-cells expressing a ganciclovir-sensitive HSV-tk suicide gene for the prevention of GvHD.
    Mailly L; Leboeuf C; Tiberghien P; Baumert T; Robinet E
    Curr Opin Investig Drugs; 2010 May; 11(5):559-70. PubMed ID: 20419602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
    Weijtens M; van Spronsen A; Hagenbeek A; de Weger R; Martens A
    Exp Hematol; 2004 Oct; 32(10):962-9. PubMed ID: 15504552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
    Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
    Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes.
    Contassot E; Robinet E; Angonin R; Laithier V; Bittencourt M; Pavy JJ; Cahn JY; Hervé P; Tiberghien P
    Bone Marrow Transplant; 1998 Dec; 22(11):1097-102. PubMed ID: 9877273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
    Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
    Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].
    Xu KL; Zhu F; Du B; Gao F; Cheng H; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):303-7. PubMed ID: 17877157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
    Kornblau SM; Stiouf I; Snell V; Przepiorka D; Stephens LC; Champlin R; Marini FC
    Cancer Res; 2001 Apr; 61(8):3355-60. PubMed ID: 11309292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
    Yang J; Liu TJ; Lu Y
    Curr Eye Res; 2007 Jan; 32(1):33-42. PubMed ID: 17364733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of pseudotyped lentivirus-mediated double suicide genes to allogeneic bone marrow transplantation in mice].
    Jiang YR; Chen XL; Ma DX; Liu CS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):82-6. PubMed ID: 14990045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
    Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C
    Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
    Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The equine herpes virus 4 thymidine kinase is a better suicide gene than the human herpes virus 1 thymidine kinase.
    Loubière L; Tiraby M; Cazaux C; Brisson E; Grisoni M; Zhao-Emonet J; Tiraby G; Klatzmann D
    Gene Ther; 1999 Sep; 6(9):1638-42. PubMed ID: 10490775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes.
    Junker K; Koehl U; Zimmerman S; Stein S; Schwabe D; Klingebiel T; Grez M
    Gene Ther; 2003 Jul; 10(14):1189-97. PubMed ID: 12833128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient control of a virus-induced immunopathology by genetic immunosuppression.
    Boyer O; Cohen JL; Bellier B; Thomas-Vaslin V; Klatzmann D; Saron MF
    Gene Ther; 2000 Sep; 7(18):1536-42. PubMed ID: 11021591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O; Síma P; Kunke D
    Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.